Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy
Transthyretin amyloidosis (ATTR-amyloidosis) is a systemic progressive fatal disease, for which a modifying therapy has recently been proposed that delays the progression of the disease and improves the patient’s quality of life. The delay in the diagnosis of ATTR-amyloidosis is associated with the...
Saved in:
Main Authors: | S. S. Nikitin, S. N. Bardakov, N. A. Suponeva, I. V. Zhirov, T. A. Adyan, D. A. Grishina, R. V. Deev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2021-12-01
|
Series: | Нервно-мышечные болезни |
Subjects: | |
Online Access: | https://nmb.abvpress.ru/jour/article/view/459 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unraveling gut microbiome alterations and metabolic signatures in hereditary transthyretin amyloidosis
by: Hanyu Li, et al.
Published: (2025-07-01) -
A Clinical Case of the Hereditary Transthyretin Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-05-01) -
Hereditary transthyretin amyloidosis
by: T. A. Adyan, et al.
Published: (2020-01-01) -
Proteomic Analysis of Serum in Cardiac Transthyretin Amyloidosis: Diagnostic and Prognostic Implications for Biomarker Discovery
by: Joanna Waś, et al.
Published: (2025-07-01) -
Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis
by: Morie A. Gertz, et al.
Published: (2025-12-01)